Navigation Links
Dr Reddy’s Laboratories to challenge patents on drug

Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal and gastric ulcers.

The FDA granted the marketing exclusivity to Andrx group of the US. The loss of marketing exclusivity is a setback for Dr Reddy’s, but this will be temporary. This is to be expected in the game of patent challenges but since generic drugs provide an enormous opportunity, Dr Reddy’s Laboratories will continue to aggressively challenge the patents on other drugs.//

Apart from generic drug challenges, Dr Reddy’s Laboratories is also focusing on patent generic drugs, innovative drug deliveries and drugs which are difficult to formulate. Nothing can be as profitable as a generic drug, because of the manufacturing cost advantage. In fact, the marketing exclusivity on fluoxetine is the best thing to have happened to Dr Reddy’s in a very long time.

The next generic drug which Dr Reddy’s hopes to launch in the US is Ciprofloxacin, on which Bayer AG has a patent till December 2003. Other generic drugs in Dr Reddy’s pipeline are Olanzapine, on which Eli Lilly has a patent, and Ondansetron, on which Glaxo SmithKline Beecham has the patent, but these will be in 204.
'"/>




Page: 1

Related medicine news :

1. Dr Reddy’s Laboratories launches Hyalosy
2. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
3. Dr Reddy’s Laboratories launches Hyalosy
4. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
5. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
6. Abbott’s Laboratories R&D Capabilities Questione
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. ICMR to Set up Laboratories to Combat Bird Flu
9. Ranbaxy Laboratories to Be Aided in Drug Research
10. Bangladesh to Set Up HIV/AIDS Diagnosis Laboratories
11. Finding relief from Excruciating Headaches a challenge
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: